Fulgent Genetics, Inc. (FLGT) Dividend History

Fulgent Genetics, Inc. (FLGT) is a healthcare technology company specializing in genetic testing and related services. It provides comprehensive genetic testing solutions for healthcare providers, commercial partners, and consumers, leveraging advanced genomic analysis to assist in disease diagnosis, personalized medicine, and research. Founded in 2011, the company has evolved to become a significant player in the genetic testing industry, offering a wide array of tests in areas such as oncology, reproductive health, and rare diseases.

4399 Santa Anita Ave, El Monte, CA, 91731
Phone: 626-350-0537
Website: https://www.fulgentgenetics.com

Dividend History

Fulgent Genetics, Inc. currently does not pay dividends

Company News

Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against EchoStar, Semler Scientific, ADTRAN Holdings, and Fulgent Genetics due to alleged violations of federal securities laws and other unlawful business practices.

GlobeNewswire Inc.

Featured Companies: ADTN SATS SMLR
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Tempus AI Inc. (NASDAQ: TEM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Tempus AI, Inc. (NASDAQ: TEM) due to allegations of providing potentially misleading business information to the investing public.

GlobeNewswire Inc.

Featured Companies: SATS TEM
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of EchoStar Corporation (NASDAQ: SATS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving EchoStar Corporation, resulting from allegations of providing potentially misleading business information to the investing public.

GlobeNewswire Inc.

Featured Companies: SATS TEM
FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating potential securities law violations by Fulgent Genetics, Inc. related to the company's disclosure of a civil investigative demand from the DOJ regarding potentially false claims filed under the Uninsured Program.

Benzinga
Fulgent Genetics Revenue Tops Estimates

Fulgent Genetics, a laboratory services and therapeutic development company, reported strong Q4 2024 results, exceeding analysts' expectations. The company saw robust revenue growth and a GAAP loss, highlighting the need to focus on revenue diversification and strategic execution.

The Motley Fool

Dividend data last updated 06/07/2025 09:15:11 UTC